A NEW COMBINATION OF KNOWN AGENTS FOR TREATMENT OF ALOPECIA AREATA: A CASE-SERIES STUDY.

Area of Science:

• Dermatology
• Immunology
• Pharmacology

Background:

• Alopecia areata is an autoimmune condition causing non-scarring hair loss.
• Hair follicle autoimmune attacks lead to localized or widespread baldness.
• Diverse patterns of hair loss present clinical challenges.

Purpose of the Study:

• To evaluate the efficacy of a novel topical preparation, Freezia cream, in treating alopecia areata.
• To document the clinical presentations and treatment outcomes in patients with alopecia areata.
• To assess the improvement in hair regrowth following a three-month treatment course.

Main Methods:

• A case-series study design was employed.
• Patients with alopecia areata received treatment with Freezia cream.
• Hair loss patterns and improvement were observed over a three-month period.

Main Results:

• Significant improvement in hair regrowth was observed in multiple cases.
• The topical preparation demonstrated effectiveness across various hair loss patterns.
• Positive outcomes were noted after three months of consistent application.

Conclusions:

• Freezia cream, an Iraqi Ministry of Health-approved topical preparation, shows promise in treating alopecia areata.
• The study suggests Freezia cream is an effective therapeutic option for diverse alopecia areata presentations.
• Further research is warranted to confirm these findings in larger, controlled trials.